About
OSSTEC is a London-based medical technology startup founded in 2021, emerging from research at Imperial College London. The company specializes in developing next-generation orthopaedic implants, particularly for knee replacement surgeries. Utilizing advanced 3D-printing techniques, OSSTEC creates biomimetic, cementless implants that mimic the properties of real bone, promoting healthy tissue growth and improving implant functionality and longevity. Led by CEO Dr. Maxwell Munford, OSSTEC combines the expertise of engineers, surgeons, and commercial professionals. Their lead product focuses on partial knee replacements, with pre-clinical studies validating its performance. The company is actively pursuing regulatory approval and preparing for clinical trials, with plans to launch in the US market. OSSTEC has secured significant funding to support its development and maintains strong research collaborations with Imperial College London, fostering ongoing innovation in orthopaedic technology. Their implants aim to enhance the quality of life for patients suffering from joint conditions worldwide.
Technologies
Keywords
Company Information
- Employees17
- Founded2021
- Annual Revenue$1000000
- Total Funding$4683453
Location
43 Sutherland Road, London, England, United Kingdom, N17 0BN
